QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 210 filers reported holding QIAGEN NV in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $17,978,000 | -77.0% | 641,620 | -77.5% | 0.27% | -77.8% |
Q3 2016 | $78,331,000 | -10.6% | 2,854,629 | -29.0% | 1.20% | -14.9% |
Q2 2016 | $87,634,000 | +71.3% | 4,018,074 | +75.4% | 1.41% | +75.7% |
Q1 2016 | $51,172,000 | -19.0% | 2,290,579 | +0.2% | 0.80% | -15.3% |
Q4 2015 | $63,196,000 | -28.4% | 2,285,569 | -33.2% | 0.95% | -20.2% |
Q3 2015 | $88,227,000 | +19.1% | 3,419,661 | +14.5% | 1.19% | +29.9% |
Q2 2015 | $74,060,000 | +19.2% | 2,987,485 | +21.2% | 0.92% | +31.2% |
Q1 2015 | $62,140,000 | +4.6% | 2,465,880 | -2.6% | 0.70% | +14.4% |
Q4 2014 | $59,423,000 | -6.8% | 2,532,945 | -9.6% | 0.61% | -4.1% |
Q3 2014 | $63,770,000 | -33.3% | 2,800,635 | -28.4% | 0.64% | -17.3% |
Q2 2014 | $95,644,000 | +34.0% | 3,911,835 | +15.6% | 0.77% | +40.8% |
Q1 2014 | $71,392,000 | -2.2% | 3,385,135 | +10.4% | 0.55% | +4.8% |
Q4 2013 | $72,985,000 | +44.8% | 3,065,300 | +30.1% | 0.52% | +37.1% |
Q3 2013 | $50,405,000 | +66.1% | 2,355,380 | +54.5% | 0.38% | +65.9% |
Q2 2013 | $30,344,000 | – | 1,524,050 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcah Management LLC | 248,425 | $5,915,000 | 6.83% |
Hardman Johnston Global Advisors LLC | 3,500,284 | $83,342,000 | 5.47% |
Douglas C. Lane & Associates, Inc. | 1,892,425 | $45,059,000 | 1.50% |
HARDING LOEVNER LP | 6,997,851 | $166,619,000 | 1.29% |
CREDIT AGRICOLE S A | 7,703,028 | $183,409,000 | 0.76% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $42,407,000 | 0.73% |
MANNING & NAPIER ADVISORS LLC | 6,290,930 | $149,784,000 | 0.68% |
Orbimed Advisors | 1,927,000 | $45,882,000 | 0.67% |
FIRST NEW YORK SECURITIES LLC /NY | 45,540 | $1,084,000 | 0.66% |
PRIMECAP MANAGEMENT CO/CA/ | 19,385,944 | $461,579,000 | 0.56% |